A biotechnology enterprise plans to discover synthetic antibodies with 3-D printed lymph node tissue for future licensing to a pharma company. Financial details of the agreement between Prellis Biologics Inc. in Hayward, California and global pharmaceutical company Sanofi were not disclosed.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,